As CD8+ T cells mediate tumor cell killing through ferroptosis, synergizing the reprogramming of lipid metabolism with anti–PD-L1 immunotherapy enhances the immune system’s ability to eliminate tumor cells (10, 21). The gene discussed is CD8A; the disease is neoplasm.